Results 81 to 90 of about 7,804 (207)

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment

Frontiers in Public Health
Poliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%.
Jia Liang, Qi Zhang, Yanan Li, Lili Wang
doaj   +1 more source

Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination

Introduction: Prior research explores whether seasonal and childhood vaccines mitigate the risk of SARS-CoV-2 infection. Although there are trials investigating COVID-19 infection in response to the effects of the oral poliovirus vaccine (OPV), there has
Chisom Azodoh, Lilly D. Engineer, Aditi Singh, Robin J. Larson, Yea-Jen Hsu, Erin Jackson-Ward, Brittany A. Comunale   +6 more
core   +1 more source

Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization. [PDF]

, 2017
A fractional dose of inactivated poliovirus vaccine (fIPV) administered by the intradermal route delivers one fifth of the full vaccine dose administered by the intramuscular route and offers a potential dose-sparing strategy to stretch the limited ...
Jarrahian, Courtney, Courtney Jarrahian, Sein, Carolyn, Carolyn Sein, Hiromasa Okayasu, Alejandro Ramirez Gonzalez, Darin Zehrung, Gonzalez, Alejandro Ramirez, Macklin, Grace, Chang Blanc, Diana, Roland W. Sutter, Zehrung, Darin, Sutter, Roland W, Okayasu, Hiromasa, Grace Macklin, Diana Chang Blanc   +15 more
core   +1 more source

Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study [PDF]

Aims and background: Despite the support of the Global Alliance for Vaccines and Immunization, developing countries still struggle to afford inactivated polio vaccine (IPV).
Sangita Yadav, Raghvendra Singh, Archana Thakur, Kunal Kumar   +3 more
core   +1 more source

Immunogenicity and Reactogenicity of DTPa-IPV/Hib Vaccine Co-administered With Hepatitis B Vaccine for Primary and Booster Vaccination of Taiwanese Infants

Journal of the Formosan Medical Association, 2011
Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (Hib) conjugate vaccine (DTPa-IPV/Hib, Infanrix™-IPV + Hib) was assessed when co-administered with hepatitis B ...
Pei-Lan Shao, Chun-Yi Lu, Yu-Chia Hsieh, Hans L Bock, Li-Min Huang   +4 more
doaj   +1 more source

The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India

Background: In 2016, the Global Polio Eradication Initiative (GPEI) recommended the cessation of using type 2 oral poliovirus vaccine (OPV) and OPV, with countries having to switch from the trivalent to bivalent OPV (bOPV) with the addition of ...
T. Jacob John, Padmasani Venkat Ramanan, Lalitendu Mohanty, Shailesh D. Pawar, Sharad Agarkhedkar, Pradeep Haldar   +5 more
core   +1 more source

Fractional-dose inactivated poliovirus vaccine, India

Bulletin of the World Health Organization, 2019
In 2016, the World Health Organization (WHO) announced a global shortage of inactivated poliovirus vaccine that was expected to last until 2020 at least. In response, WHO's Strategic Advisory Group of Experts on Immunization recommended that countries consider a strategic shift to fractional-dose inactivated poliovirus vaccine, which involves a new ...
Haldar, Pradeep, Agrawal, Pankaj, Bhatnagar, Pankaj, Tandon, Rajiv, McGray, Sarah, Zehrung, Darin, Jarrahian, Courtney, Foster, Jennifer   +7 more
openaire   +2 more sources

Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.

, 2016
The poliovirus vaccine field is moving towards novel vaccination strategies. Withdrawal of the Oral Poliovirus Vaccine and implementation of the conventional Inactivated Poliovirus Vaccine (cIPV) is imminent.
Jerome H H V Custers, Laura E. Crawt (2584468), Barbara P Sanders, Eckard Wimmer (243016), Eckard Wimmer, Gillian Cooper, Roland Zahn (113319), Laura E Crawt, Jeronimo Cello (2584456), Javier Martín, Isabel de los Rios Oakes (2584459), Barbara P. Sanders (2584447), Hanneke Schuitemaker (85702), Jeronimo Cello, Diana Edo-Matas, Taco G. Uil (2584453), Javier Martín (2584444), Jerome H. H. V. Custers (2584462), John Lewis (376957), Roland Zahn, Tobias Kamphuis, Isabel de Los Rios Oakes, Tobias Kamphuis (323601), Vladimir van Hoek (2584465), Vladimir van Hoek, Viki Bockstal (215976), Yutong Song, Taco G Uil, John Lewis, Yutong Song (327091), Hanneke Schuitemaker, Viki Bockstal, Gillian Cooper (2584450), Diana Edo-Matas (125514)   +33 more
core   +1 more source

Polio control after certification: major issues outstanding

Bulletin of the World Health Organization, 2004
Now that the global eradication of wild poliovirus is almost within sight, planning for the post-certification era is becoming a priority issue. It is agreed that a stockpile of appropriate polio vaccines will need to be established, and a surveillance ...
Fine Paul E.M., Oblapenko George, Sutter Roland W.   +2 more
doaj  

Poliovirus

, 2011
Despite marked progress in global polio eradication, the threat of polio importation into the United States remains; therefore, all children should be protected against the disease.
null null
core   +1 more source